Observational Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jan 26, 2024; 12(3): 503-516
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.503
Table 1 Clinical characteristics of patients with suspected Angelman syndrome

Number of patients
Percentage (%)
Gender33 male; 17 female
Hypotonia100
Neck support(32/50)64
Walk without support(21/50)42
Sitting without support(38/50)76
Absent speech(40/50)80
Developmental delay50/50)100
Severe mental retardation(50/50)100
Microcephaly(44/50)88
Macrostomia(40/50)80
Clinical seizures(44/50)88
Occipital groove(45/50)90
Protruding tongue(43/50)86
Wide-spaced teeth(35/50)70
Prognathism(40/50)80
Unusually light hair or skin color(13/50)26
Easily provoked laughter(50/50)100
Hyperactivity(48/50)96
Gastro-esophageal reflux(40/50)80
Ataxic movements(48/50)96
Frequent drooling(47/50)94
History of sleep difficulties(45/50)90
Fascination with water(40/50)80
Autistic behavior(14/50)28
Table 2 Primer pairs used for single strand conformation polymorphism
Exon and primers
Forward and reverse primers (5’->3’)
Region
Annealing temperature (℃)
7
Ex7FGCC ACC TGA TCT GAC CAC TIntron52
Ex7RGCA GTC TAG GGC AAC TCA AAIntron
8
Ex8AFGCC TTG ATG ATA TGT TGA GCIntron55
Ex8ARAAT TCT AGC GCC TTT CTT GTExon
Ex8BFGCC TGC ACG AAT GAG TTT TGTExon55
Ex8BRAGT TAT TAT TCC TGT CCG TTA CCIntron
9
Ex9AFTGT TTG GCT GTT TTA CTT TTA GAIntron55
Ex9ARGGC ATC AAT ATC CAC AGA CAC AExon
Ex9BFAGA AGC ATC TTC CTC AAG GExon55
Ex9BRCAC TTC CCC TCC CAC TACExon
Ex9CFCAA TGA ATT TAA CAG TCG AExon55
Ex9CRCAT CAT CTA TGA TAT GGT CAC GExon
Ex9DFCGC ATG TAC AGT GAA CGA AGA AExon55
Ex9DRTGC ACA GGA ACA ACA AAA GTA TIntron
10
Ex10FGTT TGC TTT CTG TTT CCA TTT ACIntron52
Ex10RATC CTT CTT TTG CTG CTC TTCIntron
11
Ex11FCAA TGT TGC ATG CCT AAT TAC AIntron
GGT ACT TCG GTC AGA TTA AAA CIntron
12
Ex12FGGG GAC TGG AGG GAT ACT GTIntron55
ACA TGC TTT GAA AGT GTT AAT GIntron
13
Ex13FGAA ATT GTT AAG AAG TAG GTGIntron52
Ex13RATA TGT CTT AGT TAT CTG CTAIntron
14
Ex14FAGG TGT CTG CAA AAA GTCIntron55
Ex14RTTA GCT CTG AAA AAT GGT GIntron
15
Ex15FATA ATG AAT GCC AAA CTG AAIntron55
Ex15RATA TGT ATG TGA CGA GGA ATGIntron
16
Ex16FCCC ATG ACT TAC AGT TTT CCT GIntron55
Ex16RAAG AAG GGA GGC ACA GAC ATIntron
Table 3 Ubiquitin-protein ligase E3A polymorphisms detected in our group of clinically diagnosed Angelman syndrome patients. The nucleotide and codon positions refer to the complete ubiquitin-protein ligase E3A cDNA sequence
Four common polymorphisms
New polymorphisms
c.2064+9T>C → rs79328837 (intro13)c.2220+14T>C (intron14)
c.1713A>G → RS34670662 (exon 11)c.30-47_30-46 insT (Exon7)
c.2221-40_2221-38delGTA, RS149854051 (intron 14)c.2507+43T>A (Exon15)
c.486A>T; p.Ala162 =, RS28528079 (exon9A)
Table 4 Identified exonic variants in the first consanguineous family
Gene (gene)
SHPRH
SLC30A9
HBS1L
TAAR6
TAAR2
SASH1
LOC100287896
PCF11
ANKRD42
PDGFD
DIXDC1
Chromosome6466661111111111
Location (varLocation)ExonicIntronicintronicExonicExonicExonicExonicExoticExonicExonicExonic
Effect (codingEffect)NonsynonymousNonsynonymousNonsynonymousNonsynonymousNonsynonymousNonsynonymousNonsynonymousNonsynonymousNonsynonymous
cDNA (cNomen)c.4331C>Tc.528-7T>Cc.2043+5T>Gc.865C>Tc.467C>Tc.1126C>Tc.4C>Tc.3355C>Tc.676A>Gc.7C>Gc.226G>A
Protein (pNomen)p.A1444Vp.P289Sp.T156Ip.P376Sp.R2Cp.H1119Y [Histidine (His)- Tyrosine (Tyr)]p.N226D [Asparagine (Asn)- Aspartic Acid (Asp)]p.R3G [Arginine (Arg)- Glycine (Gly)]p.G76S [Glycine (Gly)- Serine (Ser)]
Pathogenicity09/11This mutation probably has no impact on splicingActivation of an intronic cryptic donor site.07/1110/1109/1108/1109/1103/Nov0/11
Potential alteration of splicing
GME Variome (%)Not availableNot availableNot available0.1Not availableNot availableNot available0.10.10.1Not available
Gnomad browser (%)0.00080.040.20.0060.0010.0010.40.20.30.010.002
Table 5 Identified exonic variants in the second consanguineous family
Gene (gene)
KMT5A
KMT5A
STK36
PIK3CB
GPR149
RARRES1
KPNA4
NOS1
CAMKK2
WDR66
SBNO1
Chromosome12122333312121212
Location (varLocation)ExonicExonicExonicExonicExonicExonicExonicExonicExonicExonicIntronic
Effect (codingEffect)Non-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymousNon-synonymous
cDNA (cNomen)c.904>Cc.995>Cc.2516 Ac.2150>Gc.1404A>Cc.230C>Tc.1103>Gc.1922>Tc.1612_1614dupAAAc.196_197insAGAAAGAGGAGGAGGc.3220+5C>G
Protein (pNomen)p.C302Rp.L332Pp.R839Qp.N717Sp.R468Sp.P77Lp.N368Sp.A641Vp.K538dupp.E65_G66insEKEEENo significant splicing motif alteration detected. This mutation probably has no impact on splicing
Pathogenicity 03/1110/1106/1101/1101/1110/1103/1109/1101/1101/11Not available
GME Variome (%)Not availableNot available0.050.90.1Not availableNot availableNot availableNot availableNot available0.01
Gnomad browser (%)Not availableNot available0.70.10.040.0040.003Not available12Not available0.01
Table 6 Gene expression in both Family 1 and Family 2
Gene
Function
Gene expression in Family 1
TAAR2Relevance to brain function and behavior, including schizophrenia, depression, anxiety, and drug addiction
CITED2Gene is identified in human endothelial cells and neonatal brain. It is implicated in the development of the heart and neural tube
HPRHUbiquitously expressed protein that contains motifs characteristics of several DNA repair proteins, transcription factors, and helicases. A possible candidate for the tumor suppressor gene
SASH1Highly expressed in brain, heart, lung, ovary, and kidney. It is also identified as a candidate tumor suppressor gene in breast cancer
DIXDC1Highly expressed in the brain and in specific brain regions; important in embryonic cortical development
SLC30A9Shows ubiquitous expression in various human tissues, with high expression in the fetal brain, cerebellum, skeletal muscle, and kidney. Sub-cellular localization studies suggested that it is expressed in the vesicular cytosolic compartment, possibly in the endoplasmic reticulum
Gene expression in Family 2
KMT5AIs a lysine methyl-transferase that predominantly mono-methylates lysine-20 (K20) of histone H4
SETD8Influences transcriptional regulation, heterochromatin formation, genomic stability, cell cycle progression, and development
STK36Important for brain development
PIK3CBPlays a role in systemic insulin-like growth factor (IGF1) regulation and human longevity
RARRES1Implicated in hyperproliferation, inflammatory skin diseases and, prostate cancer
GPR149Increases fertility in mice, and causes prostatic cancer
NOS1Important for the brain and peripheral nervous system
SBNO1Implicated in cognition and psychoses, essential roles in vertebrate brain development